Congratulations to Neeraj Narula on his publication, “Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab” https://t.co/g87FB3LWir.
1,005 followers
4,477 followers
RT @EdwardLoftus2: Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalim…
464 followers
RT @EdwardLoftus2: Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalim…
7,182 followers
RT @EdwardLoftus2: Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalim…